202650 papers
ZO-1 shuttles between apical junctional complexes and podosomes by riding ERK activation waves.
Hirano S et al. Nat Commun. 2026
M6A-dependent upregulation of ZNF460 promotes epithelial-mesenchymal transition and metastasis of gastric cancer through a histone modification-mediated positive feedback loop.
Yue B et al. Oncogene. 2026
ZNF296 Drives Immune Evasion in Epithelial Cancers by Repressing Immune Stimulatory Genes.
Wang H et al. Cancer Res. 2026
ZNF274 constrains lineage plasticity and drives intrinsic resistance to CDK7 inhibitors in pancreatic cancer.
Gianopulos JE et al. Nat Commun. 2026
A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma.
Zhuo M et al. Cancer Cell. 2026
Stem cells as an essential mediator of the exercise-tumorigenesis link.
Zhuang X et al. Nat Rev Cancer. 2026
microRNA-25 drives immune checkpoint therapy resistance by repressing innate and humoral immunity via Syndecan-3.
Zhu Z et al. Nat Commun. 2026
Apoptosis-inducing factor starts its activity within mitochondria revealed by in situ vibrational probes.
Zhu J et al. Proc Natl Acad Sci U S A. 2026
Activating p53Y220C with a mutant-specific small molecule.
Zhu X et al. Nat Commun. 2026
Mitochondrial glutamine import sustains electron transport chain integrity independently of glutaminolysis in cancer.
Zhu L et al. Mol Cell. 2026
Testosterone and cancers: biological functions, molecular mechanisms and therapy.
Zhou Z et al. Mol Cancer. 2026
Tissue-specific tolerance mechanisms and lymph node co-drainage shape T cell immunity in the upper digestive system and pancreatic cancer progression.
Zhou YD et al. Cell Rep. 2026
Targeting inflammatory microenvironments: overcoming therapy resistance and immunosuppression.
Zhou Y et al. Mol Cancer. 2026
Cancer stem cell-driven drug resistance in colorectal carcinoma: molecular aspects and therapeutic potentials.
Zhou M et al. Mol Cancer. 2026
Multi-center multi-omics integration predicts individualized prognosis in medullary thyroid carcinoma.
Zhou Y et al. Nat Commun. 2026
Metabolic characteristics in hepatocellular carcinoma: amino acid metabolic reprogramming.
Zhou R et al. Mol Cancer. 2026
Extracellular Vesicle-Packaged miR-99a Reprograms Fibroblasts to Create an Inflammatory Niche That Drives Colorectal Cancer Metastasis.
Zhou M et al. Cancer Res. 2026
Q&A with Hua Zhong.
Zhong H et al. Cell Rep. 2026
Targeting mitochondrial homeostasis as a cancer treatment strategy: current status and future prospects.
Zhong H et al. Mol Cancer. 2026
Interpretable, flexible and spatially aware integration of multiple spatial transcriptomics datasets from diverse sources.
Zhao J et al. Nat Genet. 2026
Neoadjuvant toripalimab plus CapeOX in locally advanced Epstein-Barr virus-associated gastric or gastroesophageal junction adenocarcinoma: a phase Ⅱ trial.
Zhao L et al. Nat Commun. 2026
Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer.
Zhao Q et al. Cancer Cell. 2026
Insight of immune checkpoint blockades in melanoma: mechanism and clinical translation.
Zhang Q et al. Mol Cancer. 2026
Ki-67 promotes circulating tumor cell intravasation and metastasis in breast cancer.
Zhang Y et al. Cell Rep. 2026
Tumors mimic the niche to inhibit neighboring stem cell differentiation.
Zhang Y et al. Elife. 2026
Non-invasive profiling of the tumour microenvironment with spatial ecotypes.
Zhang W et al. Nature. 2026
Cancer cachexia: A tumor-driven disorder of whole-body homeostasis.
Zhang Y et al. Cancer Cell. 2026
Molecular insights into early malignant transition of hepatocellular carcinoma.
Zhang Z et al. Cancer Cell. 2026
Sensory neurons drive immune exclusion by stimulating a dense extracellular matrix in the breast cancer tumor microenvironment.
Zhang SW et al. Cell. 2026
Covalent modification of a glutamic acid inspired by HaloTag technology.
Zhang R et al. Nat Commun. 2026
Mitochondrial protein carboxyl-terminal alanine-threonine tailing promotes human glioblastoma growth by regulating mitochondrial function.
Zhang B et al. Elife. 2026
Genomic evolution of pancreatic cancer at single-cell resolution.
Zhang H et al. Nat Genet. 2026
Lactate: elucidating its indispensable role in human health.
Zhang S et al. Mol Cancer. 2026
Innate immunity in tumour immunoediting and immunosurveillance.
Zhang Z et al. EMBO J. 2026
ZFTA-RELA ependymomas make itaconate to epigenetically drive fusion expression.
Natarajan SK et al. Nature. 2026
Mechanisms of tumor-derived extracellular vesicle-mediated immunometabolic reprogramming and immunotherapeutic resistance.
Zeng H et al. Mol Cancer. 2026
Multiscale imaging on proton pump-driven acidity for assessing tumor progression and metastasis.
Zeng S et al. Nat Commun. 2026
Targeting ZDHHC12-mediated PARP1 palmitoylation potentiates PARP inhibitor cytotoxicity.
Zhang X et al. Cell Rep. 2026
ZC3H13 Loss Drives Cancer Metastatic Progression by Disrupting m6A RNA Methylation.
Monteagudo-García Ó et al. Cancer Res. 2026
Epigenetic reactivation of the tumor suppressor ZBTB7A by KDM4 inhibition in human acute myeloid leukemia.
Arnuk A et al. Sci Transl Med. 2026
Mechanical compression induces neuronal apoptosis, reduces synaptic activity, and promotes glial neuroinflammation in mice and humans.
Zarodniuk M et al. Proc Natl Acad Sci U S A. 2026
Drink Responsibly: Cancer Cells Also Like Sugary Drinks.
Zani F et al. Cancer Res. 2026
Damage-induced i-loops generate eccDNA from repetitive elements.
Zanella E et al. Mol Cell. 2026
Aneuploidy patterns in colorectal cancer.
Zaalberg IC et al. Cell Rep. 2026
The YY1-KIF15-PRDX1 axis promotes gastric cancer progression by inducing mitochondrial ROS imbalance.
Li W et al. Oncogene. 2026
Rethinking immune states in brain metastasis.
Yuan X et al. Cancer Cell. 2026
A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune Architecture.
Yu K et al. Cancer Discov. 2026
Genome-wide sweeps create ecological units in the human gut microbiome.
Yu XA et al. Nature. 2026
Integrated single-cell and spatial transcriptomic profiling decodes lineage plasticity and immune microenvironment remodeling in prostate cancer progression.
Yu H et al. Mol Cancer. 2026
An engineered linear cap-independent mRNA vaccine with intrinsic adjuvanticity induces potent anti-tumor immunity in mice.
Yu H et al. Nat Commun. 2026